Single T factors predict survival of patients with resected stage-IIB non-small-cell lung cancers

European Journal of Cardio-thoracic Surgery

Volumn 39, Issue 5, 2011, Pages 745-748

  Suzuki, Makoto ^a,b   Yoshida, Shigetoshi ^a   Moriya, Yasumitsu ^a   Hoshino, Hidehisa ^a   Mizobuchi, Teruaki ^a   Okamoto, Tatsuro ^a   Yoshino, Ichiro ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Non small cell lung cancer; Prognosis; Stage IIB; TNM

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67;

AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; TREATMENT OUTCOME;

EID: 79954615441     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.08.014     Document Type: Article

References (15)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Fukui T., Mori S., Hatooka S., Shinoda M., Mitsudomi T. Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancers. J Thorac Cardiovasc Surg 2008, 136:1343-1348.
3. Suzuki M., Yoshida S., Tamura H., Wada H., Moriya Y., Hoshino H., Shibuya K., Yoshino I. Applicability of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers. Eur J Cardiothorac Surg 2009, 36:1031-1036.
4. Kameyama K., Takahashi M., Ohata K., Igai H., Yamashina A., Matsuoka T., Nakagawa T., Okumura N. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution. J Thorac Cardiovasc Surg 2009, 137:1180-1184.
5. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., Postmus P.E., Rusch V., Sobin L. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706-714.
6. Sawabata N., Asamura H., Goya T., Mori M., Nakanishi Y., Eguchi K., Koshiishi Y., Tsuchiya R., Okumura M., Miyaoka E., Fujii Y. A Japanese Lung Cancer Registry Study at 2002 Japanese Joint Committee for Lung Cancer Registration. Jap J lung Cancer 2009, 49:975-987.
7. Rena O., Massera F., Robustellini M., Papalia E., Delfanti R., Lisi E., Pirondini E., Turello D., Casadio C. Use of the proposals of the International Association for the Study of Lung Cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients. Cancer J 2010, 16:176-181.
8. Yoshino I., Nakanishi R., Osaki T., Hasuda S., Taga S., Takenoyama M., Yoshimatsu T., Yasumoto K. Postoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastasis. Ann Thorac Surg 1997, 64:809-813.
9. Oliaro A., Filosso P.L., Cavallo A., Giobbe R., Mossetti C., Lyberis P., Cristofori R.C., Ruffini E. The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system. Eur J Cardiothorac Surg 2008, 34:438-443. [discussion 443].
10. Rami-Porta R., Ball D., Crowley J., Giroux D.J., Jett J., Travis W.D., Tsuboi M., Vallieres E., Goldstraw P. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007, 2:593-602.
11. Ou S.H., Zell J.A. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry. J Thorac Oncol 2008, 3:216-227.
12. Chapelier A., Fadel E., Macchiarini P., Lenot B., Le Roy Ladurie F., Cerrina J., Dartevelle P. Factors affecting long-term survival after en-bloc resection of lung cancer invading the chest wall. Eur J Cardiothorac Surg 2000, 18:513-518.
13. Matsuoka H., Nishio W., Okada M., Sakamoto T., Yoshimura M., Tsubota N. Resection of chest wall invasion in patients with non-small cell lung cancer. Eur J Cardiothorac Surg 2004, 26:1200-1204.
14. Pisters K.M., Evans W.K., Azzoli C.G., Kris M.G., Smith C.A., Desch C.E., Somerfield M.R., Brouwers M.C., Darling G., Ellis P.M., Gaspar L.E., Pass H.I., Spigel D.R., Strawn J.R., Ung Y.C., Shepherd F.A. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 2007, 25:5506-5518.
15. De Pas T., Raimondi S., Pelosi G., Spaggiari L., De Braud F., Veronesi G., Maisonneuve P. A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer. Acta Oncol 2010, 49:480-484.